BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 29, 2004
View Archived Issues
Lovastatin reduces expression of ER-alpha in human breast cancer cell lines
Read More
Synergistic action of rosiglitazone and gemcitabine observed in pancreatic cancer cell lines
Read More
Novel antinociceptive effects and pharmacokinetics reported for SCIO-469, a p38 MAPK inhibitor
Read More
New antibacterial oxazolidinones prepared and tested at Pfizer
Read More
New antitumor lamellarin analogues developed at PharmaMar
Read More
Predix presents new NK1 antagonists for asthma, pain, emesis, etc.
Read More
Novel DPP-IV inhibitors under study at Takeda
Read More
Novel progesterone receptor modulators and their use in contraception and gynecological disorders
Read More
New mGluR5 antagonists discovered by AstraZeneca and NPS team
Read More
Positive results from phase III indiplon trials
Read More
Follistim-AQ receives FDA approval
Read More
Loss of allergen sensitization reported in children between two and four years of age
Read More
New data on the use of epinephrine in the treatment of allergies
Read More
Prevention of HBV reactivation during chemotherapy in breast cancer patients
Read More
A HER-2 protein vaccine shows promise in breast cancer immunotherapy
Read More
BMS-068645 enters phase II trials
Read More
Orphan drug designation for pirfenidone for IPF
Read More
Active Biotech TTS candidate drug shows promise in pancreatic cancer
Read More
Pivotal study for PW-2102 meets primary endpoint
Read More
Shire to develop extended release formulations of Q-8003
Read More
Enrollment completed in phase IIIb Xyrem study
Read More
Inspra approved in Netherlands
Read More
Enhance Biotech selects Covance to test LI-313 compound in clinic
Read More
Aventis submits new U.S. and E.U. regulatory submissions for Taxotere
Read More
Enhanced efficacy of chemotherapy when used with OncoVEX in tumor models
Read More
European CPMP recommends approval of Erbitux in colorectal cancer
Read More
Merck to discontinue development of EMR-62203
Read More
SGN-40 enters phase I trial for multiple myeloma
Read More
German consortium to develop TB vaccine
Read More
Novel retinoid-related ligand presented by Allergan at AACR meeting
Read More
Antitumor activity of JNJ-7706621, an orally available CDK inhibitor, demonstrated in vivo
Read More
Final results of the ACTION I study for pimagedine in diabetic nephropathy
Read More
Patient exposure and response to pregabalin in GAD
Read More
Novel PDE5 inhibitor for erectile dysfunction by Schering Plough
Read More